Latest

63 moons technologies limited. (ZOFCD's) of FV Rs. 1,00,000/- each amounting to Rs. 60 crores.

the Rights Issue of the Company.

Deloitte Haskins & Sells LLP, Statutory Auditors of the Company, have issued audit reports. Recommended a Final Dividend of Rs. 18/-per equity share having face value of Rs. 10/. financial year 2024-25 will be Rs. 30/-per equity share having face value of Rs.10/-each.

Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has. Recommended a dividend of Rs. 11/- (550%) per Equity Share having face value. of Rs. 2/- each, subject to approval of the Shareholders at the ensuing Annual.

Statement of deviation(s) or variation(s) under Reg. please find attached Statement of deviation relating to the use of proceeds of Rights Issue, from the objects. stated in the Letter of Offer for Rights Issue dated June 12, 2024 duly reviewed by the Audit Committee.